fr   en

Tableaux synoptiques (en anglais)

Parcourir par date
Rechercher par mot clé
Date: 2010-02-28
Acquiring pharma company: Merck KGaA (Germany)
Acquired biotech company: Millipore (USA)
Amount: $ 7.3 billion (€ 5.3 billion)
Terms of the agreement: Merck KGaA has entered into a definitive agreement under which the german group will acquire all outstanding shares of common stock of Millipore for $107 per share in cash. The acquisition will be funded through available cash and a term loan. Completion of the transaction is expected int he second half of 2010. The Millipore brand will be maintained.
Other: The transaction aims to create a word-class partner for the life science sector and to allow the company to cover the entire value chain for pharma and biopharma customers. This includes bioscience kits and reagents, process monitoring tools, services, advanced lab instruments and consumables, disposable manufacturing solutions, chromatography media and pharma raw materials.
The acquisition will leverage Merck KGaA's presence in USA. The group will also gain a critical mass in India and China.

- On July 15, 2010, Merck KGaA announced the successful completion of its acquisition of Millipore.